people
President Steve Kang of KAIST has been appointed to the Chairman of the Global Agenda Council (GAC) on the Future of Electronics of the World Economic Forum (WEF). He will serve the position for two years until September 2016.
President Kang and WEF council members co-hosted, with the government of the United Arab Emirates (UAE), the Future Circles Initiative, a future-focused, innovative brainstorming conference to help find strategies and ideas for the development of UAE. The conference took place on November 11-12, 2014 at the Mina Al Salam Hotel in Dubai.
WEF has about 80 GACs. Each council consists of 15 experts and thought leaders from the academia, industry, government, business, and non-profit sector and deals with specific issues that are important and relevant to the global community such as ageing, artificial intelligence and robotics, brain research, food and nutrition security, education, social media, and future of chemicals, advanced materials and biotechnology.
President Kang was recognized for his contribution to the advancement of science and higher education as an engineer, scholar, and professor. He led the development of the world’s premier CMOS 32-bit microprocessors while working at the AT&T Bell Laboratories. He also taught and conducted research at the University of California, Santa Cruz, and the University of Illinois, Urbana-Champaign. President Kang served as the chancellor of the University of California at Merced from March 2007 to June 2011.
-
research KAIST Shows That the Brain Can Distinguish Glucose: Clues to Treat Obesity and Diabetes
<(From left)Prof. Greg S.B Suh, Dr. Jieun Kim, Dr. Shinhye Kim, Researcher Wongyo Jeong) “How does our brain distinguish glucose from the many nutrients absorbed in the gut?” Starting with this question, a KAIST research team has demonstrated that the brain can selectively recognize specific nutrients—particularly glucose—beyond simply detecting total calorie content. This study is expected to offer a new paradigm for appetite control and the treatment of metabolic
2025-07-09 -
research KAIST Develops Novel Candidiasis Treatment Overcoming Side Effects and Resistance
<(From left) Ph. D Candidate Ju Yeon Chung, Prof.Hyun Jung Chung, Ph.D candidate Seungju Yang, Ph.D candidate Ayoung Park, Dr. Yoon-Kyoung Hong from Asan Medical Center, Prof. Yong Pil Chong, Dr. Eunhee Jeon> Candida, a type of fungus, which can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, the incidence of candidiasis has surged due to the increase in immunosuppressive therapies, medical implants, and transplantation. Korean researc
2025-07-08 -
research KAIST Presents a Breakthrough in Overcoming Drug Resistance in Cancer – Hope for Treating Intractable Diseases like Diabetes
<(From the left) Prof. Hyun Uk Kim, Ph.D candiate Hae Deok Jung, Ph.D candidate Jina Lim, Prof.Yoosik Kim from the Department of Chemical and Biomolecular Engineering> One of the biggest obstacles in cancer treatment is drug resistance in cancer cells. Conventional efforts have focused on identifying new drug targets to eliminate these resistant cells, but such approaches can often lead to even stronger resistance. Now, researchers at KAIST have developed a computational framework to pr
2025-07-08 -
event Professor Moon-Jeong Choi Appointed as an Advisor for the ITU's 'AI for Good Global Summit'
Professor Moon-Jeong Choi from KAIST’s Graduate School of Science and Technology Policy has been appointed as an advisor for "Innovate for Impact" at the AI for Good Global Summit, organized by the International Telecommunication Union (ITU), a specialized agency of the United Nations (UN). The ITU is the UN's oldest specialized agency in the field of information and communication technology (ICT) and serves as a crucial body for coordinating global ICT policies and standards. This advis
2025-07-08 -
research KAIST Presents Game-Changing Technology for Intractable Brain Disease Treatment Using Micro OLEDs
<(From left)Professor Kyung Cheol Choi, Hyunjoo J. Lee, Somin Lee from the School of Electrical Engineering> Optogenetics is a technique that controls neural activity by stimulating neurons expressing light-sensitive proteins with specific wavelengths of light. It has opened new possibilities for identifying causes of brain disorders and developing treatments for intractable neurological diseases. Because this technology requires precise stimulation inside the human brain with minimal
2025-07-07